Canada markets closed

TransCode Therapeutics, Inc. (RNAZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8200+0.1130 (+15.98%)
At close: 04:00PM EDT
0.7853 -0.03 (-4.23%)
After hours: 07:57PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
8,831
12,264
10,232
2,754
284.459
Selling General and Administrative
7,293
7,155
8,401
3,397
442.145
Total Operating Expenses
15,238
18,495
17,553
5,873
726.604
Operating Income or Loss
-15,238
-18,495
-17,553
-5,873
-726.604
Interest Expense
0
55.899
31.986
95.07
394.573
Total Other Income/Expenses Net
-
-
-
-876.191
-1,223
Income Before Tax
-15,230
-18,546
-17,565
-6,843
-2,344
Income Tax Expense
-
-
-
-
0
Income from Continuing Operations
-15,230
-18,546
-17,565
-6,843
-2,344
Net Income
-15,230
-18,546
-17,565
-6,843
-2,344
Net Income available to common shareholders
-15,230
-18,546
-17,565
-6,843
-2,344
Basic EPS
-652.00
-
-1.08k
-648.00
-293.76
Diluted EPS
-652.00
-
-1.08k
-648.00
-293.76
Basic Average Shares
36.097
-
16.222
10.532
7.979
Diluted Average Shares
36.097
-
16.222
10.532
7.979